C

Citius Oncology, Inc. (CTOR)

0.79

+0.06 (8.89%)

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Citius Oncology, Inc. (CTOR)

0.79

+0.06 (8.89%)

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

Cost of goods sold

0

Gross Profit

0

Operating expenses (excl. COGS)

-24M

-21M

-1M

-138K

Operating Income

-24M

-21M

-1M

-138K

Non-operating income, total

-182K

0

3M

519K

Pretax income

-24M

-21M

2M

381K

Equity in earnings

0

Taxes

-1M

-576K

0

Non-controlling/minority interest

0

After tax other income/expense

0

Net income before discontinued operations

-25M

-21M

2M

381K

Discontinued operations

0

Net income

-25M

-21M

2M

381K

Dilution adjustment

0

Preferred dividends

0

-

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

Cost of goods sold

0

Gross Profit

0

Operating expenses (excl. COGS)

-24M

-21M

-1M

-138K

Operating Income

-24M

-21M

-1M

-138K

Non-operating income, total

-182K

0

3M

519K

Pretax income

-24M

-21M

2M

381K

Equity in earnings

0

Taxes

-1M

-576K

0

Non-controlling/minority interest

0

After tax other income/expense

0

Net income before discontinued operations

-25M

-21M

2M

381K

Discontinued operations

0

Net income

-25M

-21M

2M

381K

Dilution adjustment

0

Preferred dividends

0

-

Search stocks

Citius Oncology, Inc. (CTOR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Citius Oncology, Inc. (CTOR)

Income Statement (Annual)

Income Statement (Annual)